Abstract
- How will physicians react to signifi cant market events?
- What motivates physicians' treatment decisions?
- How do referral or turf dynamics impact treatment?
- How can I thrive in the global medical markets?
Millennium Research Group knows.
What is Physician Forum?
Physician Forum is the medtech industry' s only syndicated primary market
research product that includes insights from physicians and other stakeholders
to get a true sense of how market dynamics will shift in response to major
events.
How do market events affect physician practice?
By understanding the viewpoints and practice habits of physicians, device
manufacturers can better prepare for key market events critical to their
success. Physician Forum publications feature direct feedback from relevant
specialists and insight into the impact of events on specifi c markets.
Physician Forum - Primary Market Research at a Multiclient Price
clinical trial results
With over 10 years' experience and countless proprietary resources at our fi
ngertips, Millennium Research Group is the global authority in medtech market
intelligence.
turf dynamics
Take advantage of MRG' s therapeutic area expertise and extensive physician
networks and benefi t from a multiclient price. Physician Forum combines
direct physician feedback with insights from MRG' s therapeutic specialists to
put the impact of market events on your business in perspective.
product launches
Physician Forum provides timely insight on gamechanging events, allowing you
to understand market patterns, react to changing dynamics, and prepare for
future changes.
Each Publication Gives You:
reimbursement changes
Commercial Context
Each deliverable provides a thorough analysis of the background necessary to
understand the context of the research, including information such as market
size, sales trends, and a summary of attributes of key products for key
players.
product recalls
Dollar Impact
Millennium Research Group analysts break down the key survey fi ndings to
reveal the fi nancial implications of the results.
emerging therapies
Analysis of Results
Analysts assess the importance and impact of the market event. The results are
presented in an intuitive, easy-toshare Powerpoint deliverable.
clinical trial results & product recalls
NEW in Physician Forum
Stroke Prevention in Atrial Fibrillation: Is there a Future for Left Atrial Appendage Occlusion?
Warfarin has long been the mainstay of stroke prevention in atrial brillation,
but its usefulness is hampered by multiple drug, food, and alcohol
interactions, risk of bleeding, and need for constant monitoring. Since over
90% of atrial fi brillation clots leading to strokes originate in the left
atrial appendage (LAA), recent device development has focused on ways of
sealing off the LAA. MRG' s new publication looks at the potential market for
epicardial and endocardial LAA devices, both from the perspective of current
European users, and potential US adopters.
Survey Sample
- 30 European physicians who are current users of endovascular LAA occlusion
devices
- 105 potential adopters of either endocardial or epicardial LAA occlusion
devices: 35 Interventional Cardiologists, 35 Electrophysiologists, 35 Cardiac
Surgeons.
Questions Answered
- How big is the potential market for both endocardial and epicardial LAA
devices?
- What is the ideal patient population for LAA occlusion devices?
- To what extent will novel oral coagulants such as dabigatran etexilate
(Pradaxa) and rivaroxaban (Xarelto) limit the potential for LAA occlusion
devices?
